Complementary medicine in radiation oncology : German health care professionals' current qualifications and therapeutic methods (2018) Kessel KA, Klein E, Hack C, Combs SE Journal article Pradictive Character of Immunophenotyping in peripheral Blood in Patients treated with PD-1 Immunocheckpoint Inhibitors with and without Radiotherapy (Prospective Phase IV Study ST-ICI) (2018) Hecht M, Donaubauer AJ, Harrer A, Rutzner S, Becker I, Lettmaier S, Haderlein M, et al. Conference contribution Predictors of long-term survival following radical treatment of oligometastatic NSCLC with cerebral metastases (2018) Hirschmann E, Zoske H, Weissmann T, Lettmaier S, Filimonova I, Fietkau R, Putz F Conference contribution Paragangliomas of the head and neck-local control and functional outcomes following stereotactic radiotherapy (2018) Weissmann T, Semrau S, Fietkau R, Putz F Conference contribution Multicenter quality assurance evaluation of MR-guided deep hyperthermia systems (2018) Curto S, Mulder T, Aklan B, Mils O, Schmidt M, Lamprecht U, Peller M, et al. Conference contribution Low-dose irradiation has an impact on bone metabolism as well as on local and systemic immune cell-mediated inflammation (2018) Deloch L, Rückert M, Seeling M, Nimmerjahn F, Fietkau R, Frey B, Gaipl U Conference contribution Radio(chemo)therapy does differently impact on PD-L1 and PD-L2 expression in human melanoma cell lines (2018) Derer A, Riegel D, Frey B, Fietkau R, Gaipl U Conference contribution Pretreatment vitamin D levels are associated with improved overall survival following combined chemoradiotherapy (2018) Putz F, Distel L, Lettmaier S, Weissmann T, Filimonova I, Fietkau R Conference contribution Mechanism of necrotic Cell Clearance by non-professional Phagocytes (2018) Hofmann A, Seeberg J, Fietkau R, Distel L Conference contribution Proliferating non-professional Phagocytes are able to generate Cell-in-Cell Structures (2018) Hofmann A, Seeberg J, Fietkau R, Distel L Conference contribution